ACA vs LLY · P/E 57, rev $2.88B vs P/E 39, rev $65.18B
Arcosa Inc (ACA) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ACA and LLY stock pages for the full models.
Not investment advice.